Ankit Mahadevia - 03 Feb 2023 Form 4 Insider Report for Spero Therapeutics, Inc. (SPRO)

Signature
/s/ Tamara Joseph, Attorney-in-Fact for Ankit Mahadevia
Issuer symbol
SPRO
Transactions as of
03 Feb 2023
Net transactions value
-$22,238
Form type
4
Filing time
06 Feb 2023, 15:15:11 UTC
Previous filing
03 Feb 2023
Next filing
30 Aug 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRO Common Stock Sale $22,238 -12,286 -1.5% $1.81 797,832 03 Feb 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted to the Reporting Person on February 1, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.
F2 Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee. Amount also includes 691,205 RSUs held by the Reporting Person.